CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress

  1. Shah, M.
  2. Grothey, A.
  3. Tebbutt, N.
  4. Xu, R.
  5. Yoshino, T.
  6. Cervantes, A.
  7. Tabernero, J.
  8. Taieb, J.
  9. Falcone, A.
  10. Xu, B.
  11. Fontaine, M.
  12. Borodyansky, L.
  13. Van Cutsem, E.
Revista:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Any de publicació: 2018

Volum: 29

Pàgines: v84

Tipus: Article

DOI: 10.1093/ANNONC/MDY151.296 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus